Table 3

Current disease modifying antirheumatic drug (DMARD) treatment in outpatients with RA in rheumatological care with respect to rheumatoid factor (1998; values are percentages)

Seropositive RA (n=5948) Seronegative RA (n=2999) Total (n=8947)
Single treatments
 Antimalarial drugs6.63-150 15.68.9
 SSZ3-151 7.63-150 11.79.0
 Parenteral gold5.16.15.4
 MTX3-151 45.73-150 36.642.7
 AZA3-151 3.32.53.1
 Other DMARDs4.74.44.6
Combination treatments
 MTX with antimalarial drugs5.63-150 3.04.7
 MTX with SSZ3.63-150 1.93.0
 Other combination with MTX5.83-150 3.24.9
 Other combination without MTX2.21.41.9
 Total of combinations17.13-150 9.514.6
Total
 Antimalarial drugs14.33-150 17.715.5
 SSZ12.714.513.3
 MTX60.83-150 44.955.5
Any DMARD90.33-150 84.488.3
  • 3-150 Differences are significant on the 0.001 level.

  • 3-151 SSZ = sulfasalazine; MTX = methotrexate; AZA = azathioprine.